Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
Open Access
- 1 November 2004
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 6 (5), 507-516
- https://doi.org/10.1016/j.ccr.2004.09.030
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- First results of a phase I and pharmacokinetic study of SU011248, a novel oral anti-angiogenic agent, in patients with advanced solid tumoursEuropean Journal of Cancer, 2002
- Inhibition of interleukin‐1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritisArthritis & Rheumatism, 2002
- Angiopoietin-2 Is Required for Postnatal Angiogenesis and Lymphatic Patterning, and Only the Latter Role Is Rescued by Angiopoietin-1Developmental Cell, 2002
- Angiopoietin‐2 plays an important role in retinal angiogenesisJournal of Cellular Physiology, 2002
- Systemically Expressed Soluble Tie2 Inhibits Intraocular NeovascularizationHuman Gene Therapy, 2001
- Angiopoietin-2 Is Implicated in the Regulation of Tumor AngiogenesisThe American Journal of Pathology, 2001
- In Situ Expression of Angiopoietins in Astrocytomas Identifies Angiopoietin-2 as an Early Marker of Tumor AngiogenesisExperimental Neurology, 1999
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formationNature, 1995
- Molecular Cloning and Characterization of Mouse TIE and TEK Receptor Tyrosine Kinase Genes and Their Expression in Hematopoietic Stem CellsBiochemical and Biophysical Research Communications, 1993